The global prefilled syringe small molecule market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market is driven by factors such as increasing prevalence of chronic diseases and rising demand for self-injection devices in emerging economies.
Neurology drugs accounted for the largest share in the global prefilled syringe small molecule market in 2017, followed by cardiovascular drugs and analgesics. The segment is expected to maintain its dominance throughout the forecast period owing to increasing prevalence of neurological disorders such as Alzheimer's disease and Parkinson's disease globally. Cardiovascular drugs are projected to be the fastest-growing segment during the forecast period due to their high usage rates among patients with cardiovascular diseases such as hypertension, coronary artery disease, heart failure, and stroke.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as diabetes and cancer is driving the growth of the Prefilled Syringe Small Molecule market.
- Increasing number of hospitalizations due to chronic diseases is also driving the growth of the Prefilled Syringe Small Molecule market.
- Increasing geriatric population base in developing countries such as China and India is also driving the growth of the Prefilled Syringe Small Molecule market 5) Rising disposable income in developing countries such as China and India will drive demand for healthcare products, including pre-filled syringes, which will further fuel demand for pre-filled syringes in these regions.
Industry Growth Insights published a new data on “Prefilled Syringe Small Molecule Market”. The research report is titled “Prefilled Syringe Small Molecule Market research by Types (Neurology Drug, Cardiovascular Drugs, Analgesics, Adjuvants, Other), By Applications (Hospital, Clinic, Research Institute, Other), By Players/Companies Teva Pharmaceutical Industries, Hospira (Pfizer), Mylan, Fresenius Kabi, Becton, Dickinson, Sanofi”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Prefilled Syringe Small Molecule Market Research Report
By Type
Neurology Drug, Cardiovascular Drugs, Analgesics, Adjuvants, Other
By Application
Hospital, Clinic, Research Institute, Other
By Companies
Teva Pharmaceutical Industries, Hospira (Pfizer), Mylan, Fresenius Kabi, Becton, Dickinson, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Prefilled Syringe Small Molecule Market Report Segments:
The global Prefilled Syringe Small Molecule market is segmented on the basis of:
Types
Neurology Drug, Cardiovascular Drugs, Analgesics, Adjuvants, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Research Institute, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva Pharmaceutical Industries
- Hospira (Pfizer)
- Mylan
- Fresenius Kabi
- Becton
- Dickinson
- Sanofi
Highlights of The Prefilled Syringe Small Molecule Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Neurology Drug
- Cardiovascular Drugs
- Analgesics
- Adjuvants
- Other
- By Application:
- Hospital
- Clinic
- Research Institute
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prefilled Syringe Small Molecule Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A prefilled syringe small molecule is a medication that is filled with a specific drug. This type of medication can be helpful for people who have difficulty taking medications by mouth.
Some of the major companies in the prefilled syringe small molecule market are Teva Pharmaceutical Industries, Hospira (Pfizer), Mylan, Fresenius Kabi, Becton, Dickinson, Sanofi.
The prefilled syringe small molecule market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Prefilled Syringe Small Molecule Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Prefilled Syringe Small Molecule Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Prefilled Syringe Small Molecule Market - Supply Chain
4.5. Global Prefilled Syringe Small Molecule Market Forecast
4.5.1. Prefilled Syringe Small Molecule Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Prefilled Syringe Small Molecule Market Size (000 Units) and Y-o-Y Growth
4.5.3. Prefilled Syringe Small Molecule Market Absolute $ Opportunity
5. Global Prefilled Syringe Small Molecule Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Prefilled Syringe Small Molecule Market Size and Volume Forecast by Type
5.3.1. Neurology Drug
5.3.2. Cardiovascular Drugs
5.3.3. Analgesics
5.3.4. Adjuvants
5.3.5. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Prefilled Syringe Small Molecule Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Prefilled Syringe Small Molecule Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Research Institute
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Prefilled Syringe Small Molecule Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Prefilled Syringe Small Molecule Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Prefilled Syringe Small Molecule Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Prefilled Syringe Small Molecule Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Prefilled Syringe Small Molecule Demand Share Forecast, 2019-2026
9. North America Prefilled Syringe Small Molecule Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Prefilled Syringe Small Molecule Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Prefilled Syringe Small Molecule Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Research Institute
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Prefilled Syringe Small Molecule Market Size and Volume Forecast by Type
9.7.1. Neurology Drug
9.7.2. Cardiovascular Drugs
9.7.3. Analgesics
9.7.4. Adjuvants
9.7.5. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Prefilled Syringe Small Molecule Demand Share Forecast, 2019-2026
10. Latin America Prefilled Syringe Small Molecule Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Prefilled Syringe Small Molecule Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Prefilled Syringe Small Molecule Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Research Institute
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Prefilled Syringe Small Molecule Market Size and Volume Forecast by Type
10.7.1. Neurology Drug
10.7.2. Cardiovascular Drugs
10.7.3. Analgesics
10.7.4. Adjuvants
10.7.5. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Prefilled Syringe Small Molecule Demand Share Forecast, 2019-2026
11. Europe Prefilled Syringe Small Molecule Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Prefilled Syringe Small Molecule Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Prefilled Syringe Small Molecule Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Research Institute
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Prefilled Syringe Small Molecule Market Size and Volume Forecast by Type
11.7.1. Neurology Drug
11.7.2. Cardiovascular Drugs
11.7.3. Analgesics
11.7.4. Adjuvants
11.7.5. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Prefilled Syringe Small Molecule Demand Share, 2019-2026
12. Asia Pacific Prefilled Syringe Small Molecule Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Prefilled Syringe Small Molecule Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Prefilled Syringe Small Molecule Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Research Institute
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Prefilled Syringe Small Molecule Market Size and Volume Forecast by Type
12.7.1. Neurology Drug
12.7.2. Cardiovascular Drugs
12.7.3. Analgesics
12.7.4. Adjuvants
12.7.5. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Prefilled Syringe Small Molecule Demand Share, 2019-2026
13. Middle East & Africa Prefilled Syringe Small Molecule Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Prefilled Syringe Small Molecule Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Prefilled Syringe Small Molecule Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Research Institute
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Prefilled Syringe Small Molecule Market Size and Volume Forecast by Type
13.7.1. Neurology Drug
13.7.2. Cardiovascular Drugs
13.7.3. Analgesics
13.7.4. Adjuvants
13.7.5. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Prefilled Syringe Small Molecule Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Prefilled Syringe Small Molecule Market: Market Share Analysis
14.2. Prefilled Syringe Small Molecule Distributors and Customers
14.3. Prefilled Syringe Small Molecule Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Teva Pharmaceutical Industries
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Hospira (Pfizer)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Mylan
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fresenius Kabi
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Becton
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Dickinson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sanofi
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
